Hematologic and Lymphoid Abnormalities in SLE

Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition

Volumn , Issue , 2013, Pages 426-437

  Karpouzas, George A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942897295     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1893-5.00034-0     Document Type: Chapter

References (92)

1. Park KU, Song J, Kim JQ Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans. J Clin Pathol 2004, 57(10):1094-1095.
2. Delanghe J, Langlois M, De Buyzere M Congenital anhaptoglobinemia versus acquired hypohaptoglobinemia. Blood 1998, 91(9):3524.
3. Liesveld JL, Rowe JM, Lichtman MA Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 1987, 69(3):820-826.
4. Voulgarelis M, Kokori SI, Ioannidis JP, et al. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 2000, 59(3):217-222.
5. Valent P, Lechner K Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr 2008, 120(5-6):136-151.
6. Nair K, Pavithran K, Philip J, et al. Cold haemagglutinin disease in systemic lupus erythematosus. Yonsei Med J 1997 Au, 38(4):233-235.
7. Mittal KK, Rossen RD, Sharp JT, et al. Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature 1970, 225(5239):1255-1256.
8. Hepburn AL, Narat S, Mason JC The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology (Oxford) 2010, 49(12):2243-2254.
9. Ruiz-Argüelles A, Llorente L The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev 2007, 6(3):155-161.
10. Bengtsson AA, Sturfelt G, Truedsson L, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000, 9(9):664-671.
11. Starkebaum G, Price TH, Lee MY, et al. Autoimmune neutropenia in systemic lupus erythematosus. Arthritis Rheum 1978, 21(5):504-512.
12. Hadley AG, Byron MA, Chapel HM, et al. Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus. Br J Haematol 1987, 65(1):61-65.
13. Kurien BT, Newland J, Paczkowski C, et al. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol 2000, 120(1):209-217.
14. Hsieh SC, Yu HS, Lin WW, et al. Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol 2003, 131(3):506-516.
15. Arenas M, Abad A, Valverde V, et al. Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus. Arthritis Rheum 1992, 35(8):979-980.
16. Matsuyama W, Yamamoto M, Higashimoto I, et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 2004, 104(1):184-191.
17. Voulgarelis M, Kokori SI, Ioannidis JP, et al. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000, 108(3):198-204.
18. Burger T, Brasch G, Keszthelyi B Iron metabolism and anaemia in systemic lupus erythematosus and rheumatoid arthritis. Acta Med Acad Sci Hung 1967, 23(2):96-104.
19. Ganz T Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 2006, 46(5):554-557.
20. Ripley BJ, Goncalves B, Isenberg DA, et al. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis 2005, 64(6):849-853.
21. Koca SS, Isik A, Ustundag B, et al. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 2008, 31(3):46-153.
22. Faquin WC, Schneider TJ, Goldberg MA Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992, 79(8):1987-1994.
23. Jelkmann W, Pagel H, Wolff M, et al. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992, 50(4):301-308.
24. Giannouli S, Voulgarelis M, Ziakas PD, et al. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 2006, 65(2):144-148.
25. Tzioufas AG, Kokori SI, Petrovas CI, et al. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia. Arthritis Rheum 1997, 40(12):2212-2216.
26. Means RT, Dessypris EN, Krantz SB Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 2006, 80(7):1639-1647.
27. Giannouli S, Voulgarelis M, Ziakas PD, et al. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 2006, 65(2):144-148.
28. Kokori SI, Ioannidis JP, Voulgarelis M, et al. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2005, 108(3):108-204.
29. Wikman A, Axdorph U, Gryfelt G, et al. Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis. Ann Hematol 2005, 84(3):150-158.
30. Valent P, Lechner K Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr 2008, 120(5-6):136-151.
31. Sokol RJ, Hewitt S, Stamps BK Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) 1981, 282(6281):2023-2027.
32. Shulman IA, Branch DR, Nelson JM, et al. Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA 1985, 253(12):1746-1748.
33. Barker RN, de Sá Oliveira GG, Elson CJ, et al. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol 1993, 23(7):1723-1726.
34. Kay MM, Marchalonis JJ, Hughes J, et al. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites. Proc Natl Acad Sci U S A 1990, 87(15):5734-5738.
35. Sturfelt G, Nived O, Norberg R, et al. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987, 30(4):382-388.
36. Lang B, Straub RH, Weber S, et al. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus 1997, 6(8):652-655.
37. Ross GD, Yount WJ, Walport MJ, et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol 1985, 135(3):2005-2014.
38. Arvieux J, Roussel B, Ponard D, et al. Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation. Clin Exp Immunol 1991, 84(3):466-471.
39. Ruiz-Argüelles A, Llorente L The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev 2007, 6(3):155-161.
40. Pirofsky B Clinical aspects of autoimmune hemolytic anemia. Semin Hematol 1976, 13(4):251-265.
41. Ruivard M, Tournilhac O, Montel S, et al. Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: a retrospective case-control study. J Clin Apher 2006, 21(3):202-206.
42. Murphy S, LoBuglio AF Drug therapy of autoimmune hemolytic anemia. Semin Hematol 1976, 13(4):323-334.
43. Serrano J [Autoimmune hemolytic anemia. Review of 200 cases studied in a period of 20 years] (1970-1989). Article in Spanish Sangre (Barc) 1992, 37(4):265-274.
44. Gürcan HM, Keskin DB, Stern JN, et al. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009, 9(1):10-25.
45. Dierickx D, Verhoef G, Van Hoof A, et al. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. J Intern Med 2009, 266(5):484-491.
46. Rivero SJ, Alger M, Alarcón-Segovia D Splenectomy for hemocytopenia in systemic lupus erythematosus. A controlled appraisal. Arch Intern Med 1979, 139(7):773-776.
47. Ahn YS, Harrington WJ, Mylvaganam R, et al. Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med 1985, 102(3):298-301.
48. Flores G, Cunningham-Rundles C, Newland AC, et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol 1993, 44(4):237-242.
49. Voulgarelis M, Giannouli S, Tasidou A, et al. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol 2006, 81(8):590-597.
50. Bailey FA, Lilly M, Bertoli LF, et al. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 1989, 32(7):901-905.
51. Fitchen JJ, Cline MJ, Saxon A, et al. Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. Am J Med 1979, 66(3):537-542.
52. Brooks BJ, Broxmeyer HE, Bryan CF, et al. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Intern Med 1984, 144(7):1474-1477.
53. Liu H, Ozaki K, Matsuzaki Y, et al. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995, 100(3):480-485.
54. Yamasaki K, Niho Y, Yanase T Erythroid colony forming cells in systemic lupus erythematosus. J Rheumatol 1984, 11(2):167-171.
55. Pyrovolaki K, Mavroudi I, Sidiropoulos P, et al. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis. Arthritis Rheum 2009, 60(2):543-552.
56. Tiefenthaler M, Bacher N, Linert H, et al. Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus. Lupus 2003, 12(6):471-478.
57. Otsuka T, Nagasawa K, Harada M, et al. Bone marrow microenvironment of patients with systemic lupus erythematosus. J Rheumatol 1993, 20(6):967-971.
58. Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003, 49(5):633-669.
59. Qian J, Yang CD Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol 2007, 26(5):807-810.
60. Kumakura S, Ishikura H, Kondo M, et al. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 2004, 14(3):205-215.
61. Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005, 64(9):1366-1369.
62. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991, 21(1):55-64.
63. Ziakas PD, Routsias JG, Giannouli S, et al. Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol 2006, 145(1):71-80.
64. Kuwana M, Kaburaki J, Okazaki Y, et al. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006, 45(7):851-854.
65. Kuwana M, Okazaki Y, Kajihara M, et al. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum 2002, 46(8):2148-2159.
66. Cervera R, Tektonidou MG, Espinosa G, et al. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations. Lupus 2011, 20(2):174-181.
67. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 Fe, 4(2):295-306.
68. Regan MG, Lackner H, Karpatkin S Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients. Ann Intern Med 1974, 81(4):462-468.
69. Parbtani A, Frampton G, Yewdall V, et al. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus. Clin Nephrol 1980, 14(4):164-172.
70. Arnal C, Piette JC, Léone J, et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 2002, 29(1):75-83.
71. Jacobs P, Wood L, Novitzky N, et al. Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial. Am J Med 1994, 97(1):55-59.
72. Boumpas DT, Barez S, Klippel JH, et al. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1990, 112(9):674-677.
73. Roach BA, Hutchinson GJ Treatment of refractory, systemic lupus erythematosus-associated thrombocytopenia with intermittent low-dose intravenous cyclophosphamide. Arthritis Rheum 1993, 36(5):682-684.
74. Quismorio F Hematologic and lymphoid manifestations of SLE. Dubois' lupus erythematosus 2007, Lippincott Williams & Wilkins, Baltimore. ed 7. D.J. Wallace, B.H. Hahn (Eds.).
75. Sailler L Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks. Clinic Rev Allerg Immunol 2008, 34(1):103-110.
76. Hall S, McCormick JL, Greipp PR, et al. Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. Ann Intern Med 1985, 102(3):325-328.
77. Wang B, Nichol JL, Sullivan JT Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther 2004, 76(6):628-638.
78. Hepburn AL, Narat S, Mason JC The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology (Oxford) 2010, 49(12):2243-2254.
79. Lansigan F, Isufi I, Tagoe CE Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in SLE: the role of ADAMTS13. Rheumatology (Oxford) 2011, 50(5):824-829.
80. Kwok SK, Ju JH, Cho CS, et al. Thrombotic thrombocytopenic purpura in SLE: risk factors and outcome: a single center study. Lupus 2009, 18(1):16-21.
81. Letchumanan P, Ng HJ, Lee LH, et al. A comparison of TTP in an inception cohort of patients with and without SLE. Rheumatology (Oxford) 2009, 48(4):399-403.
82. Michael SR, Vural IL, Bassen FA, et al. The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood 1951, 6(11):1059-1072.
83. Rivero SJ, Díaz-Jouanen E, Alarcón-Segovia D Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978, 21(3):295-305.
84. Katsanis E, Hsu E, Luke KH, et al. Systemic lupus erythematosus and sickle hemoglobinopathies: a report of two cases and review of the literature. Am J Hematol 1987, 25(2):211-214.
85. Kondo H, Date Y, Sakai Y, et al. Effective simultaneous rhG-CSF and methylprednisolone "pulse" therapy in agranulocytosis associated with systemic lupus erythematosus. Am J Hematol 1994, 46(2):157-158.
86. Capsoni F, Sarzi-Puttini P, Zanella A Primary and secondary autoimmune neutropenia. Arthritis Res Ther 2005, 7(5):208-214.
87. Vasiliu IM, Petri MA, Baer AN Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol 2006, 33(9):1878-1880.
88. Gewurz H, Page AR, Pickering RJ, et al. Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol 1967, 32(1):64-90.
89. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. Case 42-1979. N Engl J Med 1979, 301(16):881-887.
90. Kojima M, Nakamura S, Morishita Y, et al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int 2000, 50(4):304-312.
91. Larson DL Systemic lupus erythematosus 1961, Little, Brown, Boston.
92. Kaiser IH Specificity of periarterial fibrosis of the spleen in disseminated lupus erythematosus. Bull Johns Hopkins Hosp 1942, 71:31-42.